Mim CD4.1
Latest Information Update: 06 Apr 2001
At a glance
- Originator Xcyte Therapies
- Class
- Mechanism of Action Immunosuppressants; Lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 06 Apr 2001 Discontinued-Preclinical for Psoriasis in USA (Topical)
- 08 Mar 1999 New profile
- 08 Mar 1999 Preclinical development for Psoriasis in USA (Topical)